查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1777377

全球IVD契約製造市場

IVD Contract Manufacturing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 378 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2030年全球IVD契約製造市場規模將達295億美元

全球體外診斷（IVD）契約製造市場規模預計在2024年達到167億美元，預計2024年至2030年期間的複合年成長率為10.0%，到2030年將達到295億美元。耗材是本報告分析的細分市場之一，預計其複合年成長率為8.5%，到分析期結束時規模將達到172億美元。儀器細分市場在分析期間內的複合年成長率預計為12.4%。

美國市場規模估計為 45 億美元，中國市場預期複合年成長率為 13.4%

美國體外診斷（IVD）契約製造市場規模預計在2024年達到45億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到60億美元，在2024-2030年的分析期間內，複合年成長率為13.4%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為7.3%和8.7%。在歐洲，預計德國市場的複合年成長率為7.8%。

IVD契約製造市場－主要趨勢與促進因素摘要

體外診斷 (IVD)契約製造已成為全球診斷產業的重要組成部分，使醫療設備製造商能夠將試劑、耗材和診斷設備的生產委託給專業的第三方製造商。在對快速、準確的診斷解決方案日益成長的需求的推動下，IVD 公司擴大轉向受託製造廠商(CMO) 和受託製造廠商(CDMO)，以擴大生產規模、最佳化成本並加快上市時間。分子診斷、免疫測量、POCT 和伴隨診斷的日益複雜化，推動了對高品質、合規的合約契約製造方案的需求。

精準醫療、數位診斷以及日益成長的實驗室檢測自動化正在重塑體外診斷業界，導致檢測開發、試劑配製和儀器組裝業務不斷增加。醫療保健提供者正在尋求更快速、更具成本效益且可擴展的檢測解決方案，而體外診斷（IVD）契約製造正成為企業在快速發展的市場中保持競爭力的策略必需品。

技術進步如何促進 IVD契約製造？

體外診斷 (IVD)契約製造領域正在經歷重大技術進步，以提高生產效率、品管和可擴展性。其中最重要的創新之一是將自動化和機器人技術融入製造工作流程。自動化系統如今已用於液體處理、試劑分配和高通量檢測製造，從而減少了人為錯誤並提高了流程一致性。這對於分子診斷試劑套件、橫向流動化驗和免疫測量，因為這些領域的準確性和可重複性至關重要。

另一項重大突破是採用一次性生物製程技術生產體外診斷試劑和檢測組件。一次性生物反應器、微流體晶片和預填充試劑盒的使用提高了無菌性、污染控制和批次間一致性，使契約製造更加高效且經濟高效。此外，3D列印和微加工技術的進步使得診斷設備的快速原型設計和客製化成為可能，從而加快了下一代IVD解決方案的開發週期。

分子診斷和個人化醫療的興起也推動了客製化檢測開發和基於生物標記的檢測製造的改進。 IVD契約製造製造商目前正在利用高通量定序 (NGS)、基於CRISPR的檢測和數位PCR (dPCR)平台，開發針對腫瘤、感染疾病和遺傳疾病的專用診斷解決方案。此外，人工智慧 (AI) 和機器學習融入品管流程，正在改善契約製造設施的即時監控、預測性維護和批次最佳化。

哪些市場趨勢正在推動 IVD契約製造的成長？

幾個關鍵趨勢正在塑造IVD契約製造製造業，推動外包業務成長和技術創新。其中最重要的趨勢之一是對就地檢驗（POCT）和分散式診斷的需求不斷成長。從傳統的實驗室檢測轉向可攜式、快速且方便用戶使用的診斷解決方案，導致橫向流動化驗、微流體試紙和手持式分子診斷領域的製造外包夥伴關係激增。在全球對早期疾病檢測和遠距醫療的重視推動下，IVD公司正在將POCT的生產委託給精通可擴展、高品質製造的專業CMO。

另一個主要趨勢是，隨著精準醫療和標靶治療的興起，分子診斷和伴隨診斷的應用不斷擴展。製藥和生物技術公司擴大與體外診斷製造商合作，開發伴隨診斷 (CDx)，從而能夠根據基因和生物標記分析提供個人化治療方法方案。這推動了對高度專業化的契約製造服務的需求，這些服務能夠大規模生產基於 PCR、次世代定序(NGS) 和 CRISPR 的診斷檢測試劑。

IVD製造領域日益複雜的監管環境也促使企業尋求製造外包解決方案。隨著FDA、EMA和ISO 13485對診斷設備的要求日益嚴格，許多公司正在與經驗豐富的CDMO合作，這些CDMO擁有成熟的監管專業知識、檢驗的生產線以及符合良好生產規範(GMP)的設施。透過外包生產，IVD公司可以加快監管核准，降低合規風險，並確保在全球市場上保持一致的品管。

此外，最佳化供應鏈和降低成本的壓力正促使體外診斷公司將原料採購、試劑配製和設備組裝給擁有成熟採購網路和委託效益生產能力的CMO。在全球供應鏈日益中斷的背景下，製造商正在尋求能夠提供本地生產、雙重籌資策略和靈活製造能力的合約合作夥伴，以確保穩定的產品供應。

推動 IVD契約製造市場成長的因素有哪些？

體外診斷 (IVD)契約製造市場正快速擴張，這得益於幾個關鍵的成長促進因素，包括快速診斷需求的不斷成長、醫療外包趨勢以及診斷技術的進步。推動市場成長的關鍵因素之一是分子診斷和免疫診斷檢測在感染疾病、腫瘤生物標記和遺傳性疾病檢測的廣泛應用。人口老化、慢性病發病率的上升以及全球疫情防治的持續推進，推動了對高通量、可靠且經濟高效的診斷解決方案的需求激增，促使 IVD 公司轉向契約製造進行大規模生產。

另一個主要的成長要素是中小型生物技術公司擴大採用契約製造。許多新興企業和新興診斷公司缺乏內部生產能力，而是利用合約製造（CMO）來擴大生產規模、克服監管挑戰並加速市場准入。與經驗豐富的IVD契約製造合作，使這些公司能夠專注於研發創新，同時確保高品質、符合GMP標準的生產。

人工智慧和數位轉型在診斷領域日益重要的角色也推動了客製化契約製造解決方案的需求。隨著人工智慧診斷、雲端基礎測試管理平台和穿戴式生物感測器的日益普及，IVD製造商需要精通智慧製造、自動化品管和即時分析的契約製造合作夥伴。這些下一代製造解決方案正在幫助企業簡化生產流程、提高測試準確性並增強擴充性。

此外，體外診斷 (IVD)製造地的地理擴張也推動了市場成長。儘管美國、歐洲和日本繼續引領診斷創新，但亞太國家（中國、印度、韓國和新加坡）憑藉其成本優勢、熟練的勞動力以及支持生物技術和醫療技術投資的優惠政府政策，正逐漸成為主要的契約製造目的地。許多全球體外診斷 (IVD) 公司正在將製造地遷至亞太地區，以受益於更低的製造成本、強大的基礎設施和大規模生產能力。

最後，對永續性和環保製造的日益關注正在改變IVD契約製造的格局。各公司正在探索綠色製造技術、生物分解性的測試組件和節能製造程序，以最大限度地減少廢棄物、減少碳排放並遵守環境法規。永續性已成為診斷製造商和醫療保健提供者面臨的關鍵問題。

部分

類型（耗材、設備）、技術（免疫檢測、臨床化學、分子診斷、微生物學、血液學、凝血與止血、其他）、服務（製造、測定開發、其他）

受訪公司範例

  • Advanced Powder Products, Inc.
  • Argonaut Manufacturing Services
  • Avioq, Inc.
  • Beacon MedTech Solutions
  • Bio-Techne
  • Celestica Inc.
  • Donatelle
  • ERREKA Medical
  • Eurogentec
  • Fujirebio
  • Grand River Aseptic Manufacturing（GRAM）
  • Invetech
  • IRP Medical
  • IVD Research, Inc.
  • Jabil Inc.
  • Newland AIDC
  • Qosina
  • Sanmina Corporation
  • TE Connectivity
  • West Pharmaceutical Services, Inc.

人工智慧整合

我們正在利用有效的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業產業SLM 的典型規範，而是建立了一個從世界各地專家收集的內容庫，包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地以及進出口情況（成品和原始OEM）預測其競爭地位的變化。這種複雜多變的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP31706

Global IVD Contract Manufacturing Market to Reach US$29.5 Billion by 2030

The global market for IVD Contract Manufacturing estimated at US$16.7 Billion in the year 2024, is expected to reach US$29.5 Billion by 2030, growing at a CAGR of 10.0% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$17.2 Billion by the end of the analysis period. Growth in the Equipment segment is estimated at 12.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.5 Billion While China is Forecast to Grow at 13.4% CAGR

The IVD Contract Manufacturing market in the U.S. is estimated at US$4.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.0 Billion by the year 2030 trailing a CAGR of 13.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.3% and 8.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.8% CAGR.

IVD Contract Manufacturing Market - Key Trends & Drivers Summarized

In-vitro diagnostics (IVD) contract manufacturing has become an essential part of the global diagnostic industry, enabling medical device companies to outsource the production of reagents, consumables, and diagnostic instruments to specialized third-party manufacturers. With the rising demand for rapid and accurate diagnostic solutions, IVD companies are increasingly turning to contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) to scale production, optimize costs, and accelerate market entry. The growing complexity of molecular diagnostics, immunoassays, point-of-care testing (POCT), and companion diagnostics has further fueled the need for high-quality, regulatory-compliant contract manufacturing solutions.

The expansion of precision medicine, digital diagnostics, and automation in laboratory testing is reshaping the IVD landscape, leading to greater outsourcing of assay development, reagent formulation, and device assembly. With healthcare providers demanding faster, cost-effective, and scalable testing solutions, IVD contract manufacturing is becoming a strategic necessity for companies looking to stay competitive in a rapidly evolving market.

How Are Technological Advancements Enhancing IVD Contract Manufacturing?

The IVD contract manufacturing sector is experiencing significant technological advancements aimed at improving production efficiency, quality control, and scalability. One of the most critical innovations is the integration of automation and robotics into manufacturing workflows. Automated systems are now being used for liquid handling, reagent dispensing, and high-throughput assay production, reducing human error and enhancing process consistency. This is particularly beneficial for molecular diagnostic kits, lateral flow assays, and immunoassays, where precision and reproducibility are crucial.

Another major breakthrough is the adoption of single-use bioprocessing technologies for the manufacturing of IVD reagents and assay components. The use of disposable bioreactors, microfluidic chips, and pre-filled reagent cartridges has improved sterility, contamination control, and batch-to-batch consistency, making contract manufacturing more efficient and cost-effective. Additionally, advances in 3D printing and microfabrication are enabling the rapid prototyping and customization of diagnostic devices, accelerating the development cycle for next-generation IVD solutions.

The rise of molecular diagnostics and personalized medicine has also led to improvements in custom assay development and biomarker-based test manufacturing. IVD contract manufacturers are now utilizing high-throughput sequencing (NGS), CRISPR-based assays, and digital PCR (dPCR) platforms to develop specialized diagnostic solutions tailored to oncology, infectious diseases, and genetic disorders. Moreover, the incorporation of artificial intelligence (AI) and machine learning into quality control processes is improving real-time monitoring, predictive maintenance, and batch optimization in contract manufacturing facilities.

What Market Trends Are Driving the Growth of IVD Contract Manufacturing?

Several key trends are shaping the IVD contract manufacturing industry, driving increased outsourcing and technological innovation. One of the most significant trends is the growing demand for point-of-care testing (POCT) and decentralized diagnostics. The shift from traditional laboratory-based testing to portable, rapid, and user-friendly diagnostic solutions has led to a surge in contract manufacturing partnerships for lateral flow assays, microfluidic test strips, and handheld molecular diagnostics. With global health initiatives emphasizing early disease detection and remote healthcare, IVD companies are outsourcing POCT production to specialized CMOs with expertise in scalable, high-quality manufacturing.

Another major trend is the expansion of molecular and companion diagnostics in response to the rise of precision medicine and targeted therapies. Pharmaceutical companies and biotech firms are increasingly collaborating with IVD manufacturers to develop companion diagnostics (CDx) that enable personalized treatment selection based on genetic and biomarker profiling. This has fueled the need for highly specialized contract manufacturing services that can produce PCR-based, next-generation sequencing (NGS), and CRISPR-enabled diagnostic assays at commercial scale.

The increasing regulatory complexity in IVD manufacturing is also driving companies toward outsourced production solutions. With stricter FDA, EMA, and ISO 13485 requirements for diagnostic devices, many companies are partnering with experienced CDMOs that have established regulatory expertise, validated production lines, and Good Manufacturing Practice (GMP)-compliant facilities. By outsourcing production, IVD firms can accelerate regulatory approvals, reduce compliance risks, and ensure consistent quality control across global markets.

Additionally, supply chain optimization and cost reduction pressures are leading IVD companies to outsource raw material sourcing, reagent formulation, and device assembly to CMOs with well-established procurement networks and cost-efficient production capabilities. With the rise of global supply chain disruptions, manufacturers are seeking contract partners that offer localized production, dual-sourcing strategies, and flexible manufacturing capacities to ensure uninterrupted product availability.

What Is Driving the Growth of the IVD Contract Manufacturing Market?

The IVD contract manufacturing market is expanding rapidly due to several key growth drivers, including increased demand for rapid diagnostics, outsourcing trends in healthcare, and advancements in diagnostic technology. One of the primary factors propelling market growth is the widespread adoption of molecular and immunodiagnostic tests in the detection of infectious diseases, oncology biomarkers, and genetic disorders. With an aging population, rising prevalence of chronic diseases, and global pandemic preparedness, the need for high-throughput, reliable, and cost-effective diagnostic solutions has surged, leading IVD companies to rely on contract manufacturing for large-scale production.

Another major growth driver is the rising adoption of contract manufacturing by small and mid-sized biotech firms. Many startups and emerging diagnostic companies lack in-house manufacturing capabilities and instead leverage CMOs to scale up production, navigate regulatory challenges, and accelerate market entry. By partnering with experienced IVD contract manufacturers, these companies can focus on research and innovation while ensuring high-quality, GMP-compliant production.

The increasing role of AI and digital transformation in diagnostics is also fueling the need for customized contract manufacturing solutions. As AI-powered diagnostics, cloud-based test management platforms, and wearable biosensors gain traction, IVD manufacturers require contract production partners with expertise in smart manufacturing, automated quality control, and real-time analytics. These next-generation manufacturing solutions are helping companies streamline production, improve test accuracy, and enhance scalability.

Additionally, the geographic expansion of IVD manufacturing hubs is driving market growth. While the U.S., Europe, and Japan continue to lead in diagnostic innovation, countries in Asia-Pacific (China, India, South Korea, and Singapore) are emerging as key contract manufacturing destinations due to their cost advantages, skilled labor force, and favorable government policies supporting biotech and medtech investments. Many global IVD companies are shifting manufacturing operations to Asia-Pacific to benefit from lower production costs, strong infrastructure, and high-volume manufacturing capabilities.

Lastly, the increasing focus on sustainability and green manufacturing is reshaping the IVD contract manufacturing landscape. Companies are exploring eco-friendly production techniques, biodegradable test components, and energy-efficient manufacturing processes to minimize waste, reduce carbon footprints, and comply with environmental regulations. As sustainability becomes a key consideration for diagnostic manufacturers and healthcare providers,

SCOPE OF STUDY:

The report analyzes the IVD Contract Manufacturing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Consumables, Equipment); Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis, Others); Service (Manufacturing, Assay Development, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Advanced Powder Products, Inc.
  • Argonaut Manufacturing Services
  • Avioq, Inc.
  • Beacon MedTech Solutions
  • Bio-Techne
  • Celestica Inc.
  • Donatelle
  • ERREKA Medical
  • Eurogentec
  • Fujirebio
  • Grand River Aseptic Manufacturing (GRAM)
  • Invetech
  • IRP Medical
  • IVD Research, Inc.
  • Jabil Inc.
  • Newland AIDC
  • Qosina
  • Sanmina Corporation
  • TE Connectivity
  • West Pharmaceutical Services, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • IVD Contract Manufacturing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • OEM Outsourcing Strategies Accelerate Demand for End-to-End IVD Contract Manufacturing Services
    • Rising Pressure to Reduce Time-to-Market Drives Partnerships With Agile IVD CMOs
    • Surge in POC, Rapid, and Home Diagnostics Expands Need for Scalable, Flexible Manufacturing Capacity
    • Demand for OEM-Integrated Design-to-Scale Manufacturing Models Strengthens Business Case for CDMOs
    • Regulatory Complexity Across Global Markets Spurs Need for cGMP- and ISO-13485-Certified IVD Manufacturers
    • Growth in Molecular Diagnostics and PCR Platforms Boosts Demand for Specialized Assay and Cartridge Manufacturing
    • OEM Focus on Core Competency Retention Drives Strategic Outsourcing of Reagent and Consumable Production
    • Increasing Importance of Disposable Cassette and Microfluidic Device Production Fuels Market Differentiation
    • Rising Investment in Companion Diagnostics and Personalized Medicine Expands Scope of IVD CMO Engagements
    • Adoption of Digital Health and Remote Monitoring Platforms Drives Integration of IVD Hardware-Software Assemblies
    • Biotech and Start-Up Diagnostics Firms Leverage CMOs for Pilot-Through-Commercial Scaling
    • Emerging Need for Multiplex and Multi-Pathogen Test Manufacturing Supports Assay Customization Services
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World IVD Contract Manufacturing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for IVD Contract Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for IVD Contract Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Assay Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Assay Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Assay Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Immunoassay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Clinical Chemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Microbiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Hematology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Coagulation & Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Coagulation & Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Coagulation & Hemostasis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • JAPAN
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • CHINA
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • EUROPE
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for IVD Contract Manufacturing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for IVD Contract Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • FRANCE
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • GERMANY
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 125: Spain Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Spain 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 134: Russia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Russia 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for IVD Contract Manufacturing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for IVD Contract Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 164: Australia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Australia 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • INDIA
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 173: India Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: India 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: South Korea 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for IVD Contract Manufacturing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for IVD Contract Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Argentina 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Brazil 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Mexico 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for IVD Contract Manufacturing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for IVD Contract Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 260: Iran Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Iran 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 269: Israel Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Israel 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 287: UAE Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: UAE 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • AFRICA
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 305: Africa Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Africa 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030

IV. COMPETITION